2018—2019年度河北省城市结直肠癌筛查结果分析CSCD

目的分析2018—2019年河北省城市癌症早诊早治项目结直肠癌筛查结果。方法按照河北省城市癌症早诊早治中结直肠癌筛查流程,在石家庄市和唐山市选定社区中年龄40~74岁的当地居民,通过问卷调查后采用国家统一评估模型评估出高危人群,进一步通过结肠镜检查,发现早期结直肠病变,必要时通过病理进行确诊。结果 2018—2019年度,河北省城癌项目共计37849人完成结直肠癌危险因素问卷调查,评估结直肠癌高危人群6938例,总体高危率为18.33%。其中共有1230人参加了结肠镜检查,并完成病理检查465例(37.80%)。进行病理诊断者年龄主要分布在50~64岁。经结肠镜检查及病理诊断,共检出6例(0.49%)结直肠癌患者,其中结肠癌4例(0.33%)、直肠癌2例(0.16%)。结直肠癌癌前病变190例(15.45%),非进展期腺瘤/息肉250例(20.33%),炎性反应性肠道疾病168例(13.66%)。结论开展人群结肠镜筛查可以有效检出结直肠癌和癌前病变,实现结直肠癌的早期发现、早期诊断和早期干预。

Screening Results of Colorectal Cancer in Urban Area of Hebei Province, 2018-2019

Objective To analyze the screening results of colorectal cancer in urban area of Hebei Province from 2018 to 2019. Methods According to the screening process of early diagnosis and treatment of colorectal cancer in urban area of Hebei Province, we enrolled local residents aged 40-74 years from the selected communities in Shijiazhuang and Tangshan City. The high-risk populations were evaluated by national unified evaluation model after the questionnaires. The early colorectal lesions were detected by colonoscopy, and further confirmed pathologically if necessary. Results From 2018 to 2019, a total of 37849 urban residents were involved in the risk assessment of colorectal cancer, and 6938 (18.33%) cases were evaluated as the high risk population of colorectal cancer, among which 1230 cases received colonoscopy examination and 37.8%(465/1230) received pathological examination. The age of the residents who received pathological diagnosis was mainly distributed in the age group of 50-64 years. A total of 6 (0.49%) patients with colorectal cancer were diagnosed, including 4 (0.33%) cases of colon cancer and 2 (0.16%) cases of rectum cancer. The detection rates of colorectal precancerous lesion, non-advanced adenoma/polyp and inflammatory intestinal disease were 15.45%, 20.22% and 13.66%, respectively. Conclusion Colonoscopy screening could effectively detect colorectal cancer and precancerous lesions, and achieve early detection, early diagnosis and early intervention of colorectal cancer.